New investigations into retatrutide, a dual stimulant for GLP-1 and GIP receptors, are demonstrating promising effects in treating weight gain and type non-insulin-dependent diabetes. Animal evidence suggest a distinct https://shopretatrutidepeptide.com/2026/03/12/what-is-retatrutide-peptide/